InvestorsHub Logo
Followers 87
Posts 6641
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Tuesday, 02/20/2024 10:41:55 AM

Tuesday, February 20, 2024 10:41:55 AM

Post# of 42746
Management focused on diverse patient enrollment in the LIVE-AIR trial, and discovered an 8-fold improvement in treatment outcomes for Black and African-American patients. The NIH ignored that astounding find.

And now, as we have seen previously from NIH studies, we have this:

"Monday, February 19, 2024

275 million new genetic variants identified in NIH precision medicine data
Study details the unprecedented scale, diversity, and power of the All of Us Research Program...

While more research is needed before these findings can be used to tailor genetic testing recommendations for specific populations, researchers believe the difference in the number of these variants may be influenced by past studies’ limited diversity and their disease-focused approach to participant enrollment, rather than a difference in the prevalence of the variants."

https://www.nih.gov/news-events/news-releases/275-million-new-genetic-variants-identified-nih-precision-medicine-data

Hypocrites. They report their findings, but don't take steps to implement them.

I hope they have success with implementing genetic tests for diverse populations, but authorizing lenz could have a huge impact on diverse covid populations NOW.

https://www.nih.gov/news-events/news-releases/researchers-optimize-genetic-tests-diverse-populations-tackle-health-disparities